These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 2871144
1. Ketanserin: haemodynamic effects and mechanism of action. Schalekamp MA, Woittiez AJ, Wenting GJ, van den Meiracker AH, Man in 't Veld AJ. J Hypertens Suppl; 1986 Apr; 4(1):S7-12. PubMed ID: 2871144 [Abstract] [Full Text] [Related]
2. Ketanserin: a possible tool for studying the role of serotonin in hypertension. Woittiez AJ, Wenting GJ, Man in't Veld AJ, Boomsma F, Schalekamp MA. J Cardiovasc Pharmacol; 1985 Apr; 7 Suppl 7():S130-6. PubMed ID: 2412035 [Abstract] [Full Text] [Related]
3. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat. Persson B, Gradin K, Pettersson A, Hedner T. J Cardiovasc Pharmacol; 1988 Apr; 11 Suppl 1():S22-4. PubMed ID: 2459509 [Abstract] [Full Text] [Related]
6. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist. Andrén L, Svensson A, Dahlöf B, Eggertsen R, Hansson L. Acta Med Scand; 1983 Apr; 214(2):125-30. PubMed ID: 6353879 [Abstract] [Full Text] [Related]
7. The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade. van der Starre PJ, Reneman RS. J Cardiovasc Pharmacol; 1988 Apr; 11 Suppl 1():S54-61. PubMed ID: 2459516 [Abstract] [Full Text] [Related]
8. Differences in vasodilating action between ketanserin, a 5-HT2-serotonergic receptor antagonist, and terazosin, an alpha 1-adrenoceptor antagonist, in anesthetized rabbits. Ikeda K, Takata M, Tomoda F, Mikawa M, Iida H, Sasayama S. J Cardiovasc Pharmacol; 1987 Apr; 10 Suppl 3():S69-72. PubMed ID: 2446076 [Abstract] [Full Text] [Related]
9. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats. Balasubramaniam G, Lee HS, Mah SC. J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720 [Abstract] [Full Text] [Related]
11. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients. Amery A, Fagard R, Fiocchi R, Lijnen P, Staessen J, Vermylen J. J Cardiovasc Pharmacol; 1984 Jan; 6(1):182-5. PubMed ID: 6199602 [Abstract] [Full Text] [Related]
12. Comparison of single doses of ketanserin and placebo in chronic stable angina. Cameron HA, Cameron CM, Ramsay LE. Br J Clin Pharmacol; 1986 Jul; 22(1):114-6. PubMed ID: 2874825 [Abstract] [Full Text] [Related]